Evidence map›Paper›PMID 36455982›Full record

ArticleBMJ case reports2022

Painless thyroiditis incidentally diagnosed following SARS-CoV-2 infection.

Nobuhiko Nakaizumi, Shuji Fukata, Mitsuyoshi Hirokawa, Takashi Akamizu

Open access · hybridAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Thyroid dysfunction in COVID-19.Nature reviews. Endocrinology · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nobuhiko NakaizumiInternal Medicine, Kuma Hospital, Kobe, Hyogo-ken, Japan nakaizumi@kuma-h.or.jp.ORCID http://orcid.org/0000-0003-3572-4925
Shuji FukataInternal Medicine, Kuma Hospital, Kobe, Hyogo-ken, Japan.
Mitsuyoshi HirokawaDiagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo-ken, Japan.
Takashi AkamizuInternal Medicine, Kuma Hospital, Kobe, Hyogo-ken, Japan.
Kuma Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A euthyroid woman in her 50s with papillary thyroid cancer and primary hyperparathyroidism was referred to our hospital for surgery. Her surgery was scheduled for 4 months later but was postponed because she was diagnosed with COVID-19. Five months after the first visit, she was admitted to our hospital to undergo the planned thyroid lobectomy and parathyroidectomy. Her blood tests on admission showed thyrotoxicosis, with negative thyroid-stimulating hormone receptor and thyroid-stimulating antibody. Notably, her anti-thyroglobulin antibody and anti-thyroid peroxidase antibody, which were originally negative, became positive after SARS-CoV-2 infection. She was diagnosed with painless thyroiditis. Her general condition and vital signs were stable, and the surgery was cautiously performed. Histopathological examination of the resected thyroid revealed papillary thyroid carcinoma, and the findings were consistent with painless thyroiditis. Her postoperative course was uneventful, and her thyroid function improved 2 weeks after the operation.

Indexed as

Autoimmune DiseasesCOVID-19ThyroiditisThyroid NeoplasmsFemaleHumansSARS-CoV-2Thyroid Cancer, PapillaryCOVID-19Thyroid diseaseThyroiditisThyrotoxicosis

Identifiers

PMID36455982
PMCPMC9716833
OpenAlexW4310497542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.